Supplementary Table. Clinical Characteristics, treatment, and outcomes of patients with adenoid cystic carcinoma in orbit.
Case
no Age, y
Follow-up time after surgery, mo
Last follow- up status
8
thAJCC stage grouping
Histologic
subtype Treatment
Secondary treatment for recurrence
Tertiary treatment for
recurrence Remarks
1 55 217 ANED T2cN0M0 Crib Resect + Bone + RT
2 40 217 ANED T2aN0M0 Crib/Soli Resect + RT
3 43 144 ANED T2aN0M0 Crib Resect + RT Exent
4 64 145 ANED T2aN0M0 Crib/Tubu Resect + RT
5 24 111 ANED T3aN0M0 Crib Resect + RT
6 43 77 ANED T2aN0M0 Crib/Soli Resect + RT
7 17 73 ANED T1aN0M0 Crib Resect + RT
8 67 58 Dead§ T3aN0M0 Crib Resect + RT Died due to esophageal squamous cell carcinoma
9 26 41 ANED T2aN0M0 Tubu Resect + RT
10 45 43 ANED T2aN0M0 Crib Resect + RT
11 40 191 Local recurrence T2cN0M0 Tubu Resect + RT Follow-up loss after recurrence
12 44 39 DOD T4bNxM1 Crib/Tubu RT
13 39 188 ANED T4bN0M0 N/A Exent + RT
14 31 99 ANED T4bN0M0 Crib/Soli GK, Exent + Bone
15 40 25 DOD T4bN0M1 N/A RT
16 51 32 DOD T4bN0M0 Tubu Exent
17 28 25 DOD T4bN0M0 Crib/Soli CT
18 26 61 DOD T2aN0M0 N/A Resect Refuse Patient refused treatment for recurrence
19 72 78 Local recurrence T4bN0M0 Soli/Tube IACC + Resect + RT Follow-up loss after recurrence
20 43 33 DOD T4bN0M0 Soli RT, CT Primary tumor arose from nasopharynx
21 13 85 ANED T2cN0M0 N/A Resect + CT Resect Resect + RT
22 61 23 AWD T4bN0M0 Tubu Exent + RT
23 28 2 AWD T3cN0M0 N/A CT
24 64 67 ANED T2aN0M0 Crib/Tubu Resect Exent + RT
25 43 40 ANED T4bN0M0 Crib/Tubu Exent + Bone + RT
26 67 4 ANED T4bN0M0 Crib/Soli Exent
27 32 42 AWD T4aN0M0 Tubu Resect + RT Invasions to intracranial areas